Catalent (CTLT)
(Delayed Data from NYSE)
$54.28 USD
+0.49 (0.91%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $54.28 0.00 (0.00%) 5:04 PM ET
2-Buy of 5 2
C Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Catalent, Inc. [CTLT]
Reports for Purchase
Showing records 161 - 180 ( 216 total )
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Company: Catalent, Inc.
Industry: Medical - Drugs
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Catalent, Inc.
Industry: Medical - Drugs
Morning Call
Provider: KEYBANC CAPITAL MARKETS